AfricInvest

AfricInvest is a Tunis-headquartered pan-African private equity investor managing over $1B across multiple funds and vehicles, deploying $5M to $25M growth-stage checks into mature healthcare and financial enterprises across Africa. The firm has been one of Africa’s most active institutional growth investors for over two decades, with deep relationships across DFI LPs, African corporates, and regional governments. Healthcare relevance includes care delivery operations, hospital and clinic networks, healthcare infrastructure, pharma and pharmaceutical distribution, and tech-enabled care services with proven economics. Founders pursuing early-stage AI experiments, biotech assets, or pure software at Seed should look at specialist or earlier-stage funds. The right counterparty is a CEO of a mature African healthcare business with audited financials, scaled revenue, regulatory and compliance maturity, and a credible exit pathway through strategic, IPO, or secondary. AfricInvest’s institutional cadence reflects its DFI-anchored LP base and regulated PE structure: governance is formal, post-investment information rights are deep, and the firm engages at the board level. Geographic advantage is the pan-African footprint with offices across multiple jurisdictions, deep relationships with African healthcare corporates and governments, and connectivity into global PE secondary markets and strategic acquirers. Best entry is via established African banker relationships, DFI-led syndicates, or direct outreach when revenue and audited financials are at the level the firm takes seriously. The healthcare team is small and selective, so cold inbound conversion is low. Lead the pitch with audited financials, cohort and operational metrics, regulator and clinical quality systems, and a credible exit pathway. Be explicit about ESG posture, governance maturity, any material litigation or compliance history, and how the company handles cross-border operating realities including FX volatility, regulator unpredictability, and political risk. Caveats: AfricInvest’s DFI-anchored LP base imposes ESG and impact reporting requirements that pure financial PE does not, so founders should be ready for that level of disclosure and governance. Ask the firm directly about LP base specifics for the relevant fund, governance preferences, and how follow-on is handled in down cycles. Confirm fund vintage and remaining deployment, and reference current portfolio CEOs on board behavior, operating support, and value beyond capital. Used appropriately, AfricInvest is one of the most credible African growth-stage PE partners for healthcare CEOs at meaningful scale; for founders earlier in the journey, it is structurally premature.